RIBOGALPLEX
LIVE

Serial Number

99620295

Owner

Suzhou Ribo Life Science Co., Ltd.

Attorney

Zhi Dong

Filing Date

Jan 28, 2026

Add to watchlist:

No watchlists yet
View on USPTO

RIBOGALPLEX Trademark

Serial Number: 99620295

RIBOGALPLEX is a trademark filed by Suzhou Ribo Life Science Co., Ltd. on January 28, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Suzhou Ribo Life Science Co., Ltd. (10 trademarks)

168 Yuanfeng Road,

Entity Type: 16

Trademark Details

Filing Date

January 28, 2026

Registration Date

Not Registered

Goods & Services

technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; research and development services of new pharmaceutical products; research and development in the field of pharmaceuticals; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design

medicines for humans for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; crude drugs being pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; Biological preparations for use in cell cultures for medical purposes; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; diagnostic preparations for medical purposes; potassium salts for medical purposes; sodium salts for medical purposes; Pharmaceutical products for the treatment of cancer; anti-cancer preparations; Biopharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment and prevention of cancer; tumor suppressing agents; Pharmaceutical preparations for suppressing tumors; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; Anticoagulants; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dietetic foods and beverages adapted for medical use; depuratives for the body; pesticides; Medical dressings; Composite materials for dental and dental technical purposes

Filing History

APPLICATION FILING RECEIPT MAILED
Jan 28, 2026 MAFR
NEW APPLICATION ENTERED
Jan 28, 2026 NWAP